There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Alzheimer’s disease affects more than 30m people worldwide, mostly the elderly. After the age of 65, the chance of developing ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Johnson & Johnson is advancing Alzheimer’s research through precision medicine, focusing on tau-targeting therapies like ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

Widely prescribed and moderately helpful in improving cognition, the drugs are not thought to slow the underlying neurodegenerative process, as is the hope for newer Alzheimer’s treatments that ...